ATS-13® Activity Assay
What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?
ATS-13 Activity Assay provides protocols to quantitatively measure ADAMTS-13 protease activity and determine the presence of inhibitory antibodies to ADAMTS-13 in human plasma.
ADAMTS-13 is the protease that cleaves von Willebrand Factor. Significant decreases or an absence of ADAMTS-13 activity can lead to the formation of ultra-large vWF fragments and trigger iIntravascular platelet aggregation and microthrombosis, causing the signs and symptoms of thrombotic thrombocytopenic purpura, TTP.
Quick and Easy
- Set up in less than 10 minutes
- Pre-diluted calibrators
- Results in under 45 minutes
Sensitive
- Utilizes fluorescence resonance energy transfer (FRET) technology with less test variability
- % Activity and % Inhibition derived from a fluorescent endpoint
Research Use Only (RUO). Not for use in diagnostic procedures.
Resource Library
Our Certifications
Related Products
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen Completes Acquisition of Immucor, Inc.
WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and...
